Primary Care Clinics in Bottineau, ND Accepting Medicare
5 Primary Care Clinics found. Showing 1 - 5
 Block Chiropractic & Wellness Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 512 Main Street, Bottineau, ND 58318 Phone: 701-228-6924 |
St. Andrew's Hospital Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 314 Ohmer St, Bottineau, ND 58318 Phone: 701-228-9400 |
Chiropractic Arts Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 909 11th St E, Bottineau, ND 58318 Phone: 701-228-2275 Fax: 701-228-3080 |
St. Andrew's Bottineau Clinic, Llc Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 314 Ohmer St, Bottineau, ND 58318 Phone: 701-228-9400 Fax: 701-228-3245 |
Pyramid Health, Llc Clinic/Center Medicare: Medicare Enrolled Practice Location: 516 Main St, Bottineau, ND 58318 Phone: 701-534-0109 Fax: 866-640-0723 |
News Archive
Hospitalizations may be major risk factor for increased cognitive decline in older adults
Emergency and urgent hospitalizations are associated with an increased rate of cognitive decline in older adults, report researchers at Rush University Medical Center.
Surgeons describe positive outcomes in kidney cancer patients treated with robotic IVC thrombectomy
Surgery is required when cancer of the kidney causes a Level III thrombus, or clot, to develop in the major vein leading back to the heart. Traditionally this complicated procedure, inferior vena cava (IVC) thrombectomy, is performed using a large open incision, primarily because the vein is often difficult to reach.
Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
DUSA Pharmaceuticals finds place in Deloitte's Technology Fast 500 list for second consecutive year
DUSA Pharmaceuticals, Inc.(R)( )(Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that it has been named to Deloitte's Technology Fast 500 list. For the second consecutive year, Deloitte recognized DUSA as one of the Top 500 fastest growing technology, media, telecommunications and life sciences companies in North America in terms of percentage revenue growth over a five year period.
Limiting work hours for medical trainees increases the number of patient 'handoff'
Limiting the number of continuous hours worked by medical trainees failed to increase the amount of sleep each intern got per week, but dramatically increased the number of potentially dangerous handoffs of patients from one trainee to another, new research from Johns Hopkins suggests. The reductions in work hours also decreased training time, the researchers found.
› Verified 6 days ago